头孢曲松钠与头孢唑肟钠治疗下呼吸道感染的药物经济学分析.pdfVIP

2092 Chinese Journal of Medicinal Guide 2013 Volume 15 No.12 (Serial No.122) 卫生经济学 头孢曲松钠与头孢唑肟钠治疗下呼吸道感染的药物经济学分析 于海晴 (江苏省淮安市楚州医院药剂科,淮安223200) 【摘要】目的:探讨头孢曲松钠与头孢唑肟钠治疗下呼吸道感染的药物经济学价值。方法:选取20 11~20 13年两年间在我院接受治 疗的110例下呼吸道感染患者,随机分为研究1组和研究2组各55例。研究1组采用头孢曲松钠进行治疗,研究2组采用头孢唑肟钠 进行治疗,并采用药物经济学方法对两组患者的治疗方案进行成本-效果分析。结果:研究1组的总有效率略高于研究2组,但无显 著性差异(P 0.05) 。研究1组的成本-效果比值为1.96 明显低于研究2组的成本-效果比值8.49,差异具有统计学意义(P 0.05) 。治 疗过程中两组患者均未出现严重不良反应现象。结论:头孢曲松钠治疗下呼吸道感染疗效显著、安全可靠且价格低廉,具有临床 推广应用价值。 【关键词】头孢曲松钠;头孢唑肟钠;下呼吸道感染;药物经济学 【中图分类号】R956 【文献标识码】A 【文章编号】1009-0959(2013) 12-2092-02 The Pharmacoeconomic Comparison between Ceftriaxone Sodium and Ceftizoxime Sodium in Treating with Lower Respiratory Tract Infection Yu Hai-qing (Department of Pharmacy, Chuzhou Hospital of Huaian City Jiangsu Province, Huaian 223200, China) 【 】 To investigate and analyze the pharmacoeconomic comparison between ceftriaxone sodium and ceftizexime ABSTRACT Objective: sodium curing lower respiratory tract infection. Methods: One hundred and ten cases of lower respiratory tract infection cured in our hospital during 2011 to 2013 were randomly assigned to two groups.Each group had fifty-five cases and the group 1 received ceftriaxone sodium, while group 2 received ceftizexime sodium. The methods of pharmacoeconomics were employed in the comparison between the two groups cost-effectiveness analysis. Results: The total effective rate of the group 1 was higher than the group 2,but the difference was not significant (P0.05).The cost-effectiveness ratio of the group 1 was 1.96,which was significantly lower than the group 2 (P0.05). The cost-effectiveness r